Search research articles
Contact Us
Filters
Showing results (731-740 of 1,290) with videos related to
Page
of 129
Sort By:
The Journal of Clinical Ethics
|
May 3, 2000
End-of-life decision making: when patients and surrogates disagree
P B Terry, M Vettese, J Song, et al.
The Journal of Experimental Medicine
|
May 1, 1985
Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens
I Stroynowski, J Forman, R S Goodenow, et al.
Cancer
|
June 22, 2010
Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
Saro H Armenian, Can-Lan Sun, Jennifer Berano Teh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines
C P Anderson, J Tsai, W Chan, et al.
The Journal of Infectious Diseases
|
September 18, 1997
Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma
J A Zaia, G M Gallez-Hawkins, B R Tegtmeier, et al.
Blood Cells, Molecules & Diseases
|
June 30, 2004
Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies
Laurence J N Cooper, Zaid Al-Kadhimi, David DiGiusto, et al.
Acta Haematologica
|
January 1, 1982
Hemolytic uremic syndrome after bone marrow transplantation
W E Spruce, S J Forman, K G Blume, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 2, 2011
Matched-cohort analysis of autologous hematopoietic cell transplantation with radioimmunotherapy versus total body irradiation-based conditioning for poor-risk diffuse large cell lymphoma
Amrita Krishnan, Joycelynne M Palmer, Ni-Chun Tsai, et al.
Leukemia & Lymphoma
|
August 10, 2011
A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517
Mark H Kirschbaum, Bryan H Goldman, Jasmine M Zain, et al.
Gene Therapy
|
February 27, 2001
Demyelination but no cognitive, motor or behavioral deficits after adenovirus-mediated gene transfer into the brain
H M Fathallah-Shaykh, A I Kafrouni, L J Zhao, et al.
Page
of 129
Search research articles
Search
Showing results (731-740 of 1,290) with videos related to
Sort By:
Page
of 129
The Journal of Clinical Ethics
|
May 3, 2000
End-of-life decision making: when patients and surrogates disagree
P B Terry, M Vettese, J Song, et al.
The Journal of Experimental Medicine
|
May 1, 1985
Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens
I Stroynowski, J Forman, R S Goodenow, et al.
Cancer
|
June 22, 2010
Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
Saro H Armenian, Can-Lan Sun, Jennifer Berano Teh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines
C P Anderson, J Tsai, W Chan, et al.
The Journal of Infectious Diseases
|
September 18, 1997
Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma
J A Zaia, G M Gallez-Hawkins, B R Tegtmeier, et al.
Blood Cells, Molecules & Diseases
|
June 30, 2004
Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies
Laurence J N Cooper, Zaid Al-Kadhimi, David DiGiusto, et al.
Acta Haematologica
|
January 1, 1982
Hemolytic uremic syndrome after bone marrow transplantation
W E Spruce, S J Forman, K G Blume, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 2, 2011
Matched-cohort analysis of autologous hematopoietic cell transplantation with radioimmunotherapy versus total body irradiation-based conditioning for poor-risk diffuse large cell lymphoma
Amrita Krishnan, Joycelynne M Palmer, Ni-Chun Tsai, et al.
Leukemia & Lymphoma
|
August 10, 2011
A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517
Mark H Kirschbaum, Bryan H Goldman, Jasmine M Zain, et al.
Gene Therapy
|
February 27, 2001
Demyelination but no cognitive, motor or behavioral deficits after adenovirus-mediated gene transfer into the brain
H M Fathallah-Shaykh, A I Kafrouni, L J Zhao, et al.
Page
of 129